Allianz Asset Management GmbH - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2021$212,000
-90.7%
60,468
-73.9%
0.00%
-100.0%
Q1 2021$2,282,000
-11.0%
231,435
-2.1%
0.00%
-33.3%
Q4 2020$2,563,000
-7.9%
236,439
-12.5%
0.00%0.0%
Q3 2020$2,782,000
-44.4%
270,091
+12.7%
0.00%
-50.0%
Q2 2020$5,002,000
+69.4%
239,608
-20.7%
0.01%
+50.0%
Q1 2020$2,952,000
-4.0%
302,206
+13.3%
0.00%
+33.3%
Q4 2019$3,074,000
+702.6%
266,816
+279.4%
0.00%
Q3 2019$383,00070,3320.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders